IHN/MWPC Meeting 2026: Advances and Clinical Updates in Cell and Gene Therapy

Orlando, FL US
May 8, 2026
This activity will review new and emerging FDA-approved cell and gene therapy products, with a focus on key safety considerations, monitoring parameters, and adverse effect management. This program will also discuss operational, regulatory, and logistical considerations for implementation, and guidance on selecting the best therapy for a patient.

Target Audience

  • Pharmacists
  • Pharmacy Technicians

Learning Objectives

At the conclusion of this activity, pharmacists should be able to:  

  • Describe recent FDA-approved and emerging cell and gene therapies.
  • Evaluate key safety considerations, monitoring parameters, and adverse effect management strategies.
  • Discuss operational, regulatory, and logistical considerations for implementing cell and gene therapy programs within health systems.
  • Apply current evidence and clinical guidelines to optimize patient selection and therapeutic outcomes in cell and gene therapy.

 

At the conclusion of this activity, pharmacy technicians should be able to:  

  • Describe recent FDA-approved and emerging cell and gene therapies.
  • Evaluate key safety considerations, monitoring parameters, and adverse effect management strategies.
  • Discuss operational, regulatory, and logistical considerations for implementing cell and gene therapy programs within health systems.
  • Apply current evidence and clinical guidelines to optimize patient selection and therapeutic outcomes in cell and gene therapy.
Course summary
Available credit: 
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Technician
Course opens: 
05/08/2026
Course expires: 
07/07/2026
Event starts: 
05/08/2026 - 8:15am CDT
Event ends: 
05/08/2026 - 9:15am CDT
Add to calendar: 
JW Marriott Orlando Bonnet Creek
14900 Chelonia Pkwy
Orlando, FL 32821
United States
FACULTY & PLANNERS
Faculty
Emily Diehl, PharmD, BCPPS
Senior Pharmacy Executive
Vizient, Inc.
 
Planners

Elizabeth Dowell, PharmD
Sr. Project Manager, Pharmacy Aggregation Groups
ExcelerateRx
Spend Management
Vizient, Inc.

Samantha Gordon, MS
CE Programs Manager             
Vizient, Inc.

Marilu Kelly, MSN, RN, NPD-BC, CHCP
Director, Continuing Education      
Vizient, Inc.
 

DISCLOSURE

As an accredited provider of continuing education, Vizient, Inc. is dedicated to ensuring this activity presents learners with only accurate, balanced, scientifically justified recommendations, and is free from promotion, marketing, and commercial bias. In accordance with The Standards for Integrity and Independence in Accredited Continuing Education, all planners, faculty, and others in control of the educational content have disclosed the absence or existence of all financial relationships (of any dollar amount) with ineligible companies within the past 24 months.
 
Ineligible companies – those companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
 
It is Vizient’s policy that owners and employees of ineligible companies, and any individuals who refuse to disclose the absence or existence of financial relationships with any ineligible companies are disqualified from participating as planners or faculty.
 
Statement of Content Validity
Vizient, Inc. educational activities are intended to assist healthcare teams advance their professional responsibilities in accordance with the definition of continuing education. It is the policy of Vizient, Inc. to review and ensure that all content and recommendations for patient care within accredited CE is evidenced-based, based on current science and clinical reasoning while ensuring the content is fair and balanced. All recommendations must conform to the generally accepted standards of experimental design, data collection, analysis, and interpretation. Vizient, Inc. does not permit accredited continuing education if it advocates for unscientific approaches to diagnosis or therapy, or if the education promotes recommendations, treatment, or manners of practicing healthcare that are determined to have risks or dangers that outweigh the benefits or are known to be ineffective in the treatment of patients.
 
FDA Off-Label Use
Faculty presenters are also expected to disclose any discussion of (1) off-label or investigational uses of FDA approved commercial products or devices or (2) products or devices not yet approved in the United States.
Off-label/unapproved drug uses or products are mentioned within this activity.
 

Disclaimer

The education provided through this activity is for continuing education purposes only. The views and opinions expressed in this activity are those of the faculty/presenters and do not necessarily reflect the views of Vizient, Inc.
 
Disclosure Statements
 
Absence of Relevant Financial Relationships
None of the planners, faculty, or others in a position to control content for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Joint Accreditation Statement

In support of improving patient care, Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

 
Designation Statements
 
Pharmacists (CPE)
 
Vizient, Inc. designates this live activity for a maximum of 1.0 contact hours for pharmacists.
 
Universal Activity Number: JA0006103-0000-26-030-L01-P
 
Pharmacy Technicians (CPE)
 
Vizient, Inc. designates this live activity for a maximum of 1.0 contact hours for pharmacy technicians.
 
Universal Activity Number: JA0006103-0000-26-030-L01-T

Available Credit

  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Technician
Please login or register to take this course.

 

Select the “Obtain Credit” button to access the activity evaluation and to claim CE Credit.
 
Please Note: 
  • If the "Register/Take Course" tab is displayed instead of the "Obtain Credit" tab, you must first login to proceed with the credit claim process.
  • This activity requires learners to confirm their attendance using an activity code. An Access Denied error message indicates that your attendance was not recorded via SMS text or QR code scanning.
Please click here to enter the code you received at the end of the activity to verify your attendance if you have not already done so: https://continuingeducation.vizientinc.com/code

 

 

Required Hardware/software

 

The Vizient CE Learner Portal is compatible with most modern web browsers (such as Firefox, Google Chrome, Microsoft Edge, Apple Safari) and can also be accessed with mobile devices.